Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Related
Stephen Saad’s Aspen stake drops $99.7 million in 2024
This downturn is driven by a sustained decline in the market value of his holdings in Aspen Pharmacare, Africa's largest pharmaceutical company.
Aspen’s 20-percent stock decline costs South African tycoon Stephen Saad nearly $160 million
Saad's wealth drops by nearly $160 million after Aspen Pharmacare's shares tumble 20.17 percent over the past 25 days on the JSE.
Latest
Suresh Bhagwanji Shah’s stake in I&M Group gains $23 million year-to-date
This strategic move brings together two powerhouse entities and marks a significant step toward consolidating Black-led financial influence.
Jay-Z’s Marcy Ventures joins forces with Pendulum Holdings' investment arm
This strategic move brings together two powerhouse entities and marks a significant step toward consolidating Black-led financial influence.
Koos Bekker-linked family trust offloads $162 million in Prosus stock
This highlights Bekker’s approach to blending technology investments with high-end real estate, showcasing his commitment to diversified growth.
Aradel-backed consortium gets approval for $2.4 billion Shell deal
The transaction has been designed to preserve SPDC’s operational integrity post-acquisition.